BIOCARTIS
Biocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.
BIOCARTIS
Industry:
Biotechnology Health Diagnostics Medical Device
Founded:
2007-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.biocartis.com
Total Employee:
251+
Status:
Active
Contact:
41 21 694 04 30
Email Addresses:
[email protected]
Total Funding:
322.9 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Lia
Lia Diagnostics develops flush-able and eco-friendly pregnancy test.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Spero Therapeutics
Spero Therapeutics develops therapeutics for treatment of gram-negative infections.
UE LifeSciences
UE LifeSciences is a female technology company building preventive oncology solutions for primary care and home.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Flanders Innovation and Entrepreneurship (VLAIO)
Flanders Innovation and Entrepreneurship (VLAIO) investment in Grant - Biocartis
Hitachi Chemical Diagnostics
Hitachi Chemical Diagnostics investment in Series F - Biocartis
PMV Tina Fund
PMV Tina Fund investment in Series F - Biocartis
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series F - Biocartis
PMV Tina Fund
PMV Tina Fund investment in Series E - Biocartis
RMM
RMM investment in Series E - Biocartis
Philips Venture Capital Fund
Philips Venture Capital Fund investment in Series E - Biocartis
Valiance Asset Management
Valiance Asset Management investment in Series E - Biocartis
Koninklijke Philips
Koninklijke Philips investment in Series E - Biocartis
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation investment in Series E - Biocartis
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-21 | Geneprodx | Biocartis investment in Series A - Geneprodx | 3.2 M USD |
| 2012-06-19 | Immunexpress | Biocartis investment in Venture Round - Immunexpress | 2 M AUD |
Newest Events participated
Official Site Inspections
http://www.biocartis.com Semrush global rank: 2.34 M Semrush visits lastest month: 7.97 K
- Host name: 172.67.72.129
- IP address: 172.67.72.129
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biocartis"
Our company - Biocartis
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary Idylla TM Platform. We provide next generation diagnostic …See details»
About Us - Biocartis
Biocartis is an innovative molecular diagnostics company committed to revolutionizing molecular testing with its unique proprietary Idylla TM Platform. We provide next generation diagnostic …See details»
Biocartis - Crunchbase Company Profile & Funding
Organization. Biocartis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... staging, treatment selection, and monitoring of a …See details»
Biocartis - LinkedIn
Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients ...See details»
Corporate Governance Charter - Biocartis
May 22, 2018 BIOCARTIS GROUP NV Public limited liability company (naamloze vennootschap) Generaal de Wittelaan 11B, 2800 Mechelen, Belgium Register of Legal Entities …See details»
Biocartis - LinkedIn
Biocartis | 38,347 followers on LinkedIn. High precision diagnostics for personalized medicine | Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing …See details»
Biocartis Company Profile - Office Locations, Competitors, …
Oct 29, 2024 Biocartis has 5 employees across 13 locations and €57.48 m in annual revenue in FY 2022. See insights on Biocartis including office locations, competitors, revenue, financials, …See details»
Investor Relations - Biocartis Holdings Inc.
This is the investor relations page of Biocartis Holdings Inc., a privately held Delaware holding company that is the shareholder of Biocartis NV and Biocartis US Inc. This page is under …See details»
Biocartis - Overview, News & Similar companies | ZoomInfo.com
Aug 7, 2023 View Biocartis (www.biocartis.com) location in Flanders, Belgium , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Biocartis Group NV
Biocartis Group NV is a Belgian listed company registered with the register of legal entities Antwerp (division Mechelen) under company number 0505.640.808. Following the enforcement by the Biocartis Group NV’s secured creditors on …See details»
Meet the Team - Biocartis
Biocartis drives innovation and leadership in all diagnostic-related areas where its platforms and assay technologies are required. On this page you can discover the teams. ... Head of People …See details»
Press Release Biocartis Group NV: Biocartis announces H1
Sep 26, 2023 Going forward, enabling access to molecular diagnostic testing in oncology remains at the core of Biocartis’ strategy with a streamlined organization that will focus …See details»
Biocartis Company Overview, Contact Details & Competitors
Biocartis Group partnered with Eli Lilly on Aug 10th '23. Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform Mechelen, Belgium, 2023 - …See details»
Press release Biocartis Holdings Inc.: Recapitalization completed …
PRESS RELEASE - 22 November 2023, 10:00 CET BIOCARTIS HOLDINGS INC. RECAPITALIZATION COMPLETED AND PRODUCT PORTFOLIO EXPANSION The …See details»
Press release Biocartis Group NV: BIOCARTIS MEETS 2021 KEY
Jan 10, 2022 Also in May 2021, Biocartis announced the EUR 1.4 million grant it received from VLAIO, the Flanders organization for Innovation & Entrepreneurship, for the ongoing …See details»
Biocartis | Molecular Diagnostics Solutions |Create Account
Developing molecular diagnostic solutions, Biocartis works to provide direct access to personalized medicine for patients worldwide. @Biocartis_ REQUEST ACCOUNT. Your …See details»
Press release Biocartis Group NV: Biocartis Honors Breast Cancer ...
PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16 October 2023 – Biocartis …See details»
Working at Biocartis
Biocartis Vision & Mission is to enable universal access to personalized medicine for patients around the world by making molecular testing convenient, fast and suitable for any lab Core …See details»
Biocartis | flanders.bio
Feb 7, 2010 Biocartis’ proprietary molecular diagnostics (MDx) IdyllaTM platform is a fully automated sample-to-result, real-time PCR system that offers accurate, highly reliable …See details»